These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 28749559)
1. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model. Li G; Zhu Y; Shao D; Chang H; Zhang X; Zhou D; Gao Y; Lan K; Deng Q Hepatology; 2018 Jan; 67(1):56-70. PubMed ID: 28749559 [TBL] [Abstract][Full Text] [Related]
2. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice. Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718 [TBL] [Abstract][Full Text] [Related]
3. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia. Wu M; Wang C; Shi B; Fang Z; Qin B; Zhou X; Zhang X; Yuan Z Antiviral Res; 2020 Aug; 180():104826. PubMed ID: 32502604 [TBL] [Abstract][Full Text] [Related]
4. The Cre/loxP-Based Recombinant HBV cccDNA System In Vitro and In Vivo. Zheng Y; Deng Q Methods Mol Biol; 2024; 2837():185-198. PubMed ID: 39044085 [TBL] [Abstract][Full Text] [Related]
5. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation. Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308 [TBL] [Abstract][Full Text] [Related]
6. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays. Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776 [TBL] [Abstract][Full Text] [Related]
7. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus. Zhou Z; Li C; Tan Z; Sun G; Peng B; Ren T; He J; Wang Y; Sun Y; Wang F; Li W Antiviral Res; 2023 Aug; 216():105642. PubMed ID: 37253400 [TBL] [Abstract][Full Text] [Related]
8. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely. Guo X; Chen P; Hou X; Xu W; Wang D; Wang TY; Zhang L; Zheng G; Gao ZL; He CY; Zhou B; Chen ZY Sci Rep; 2016 May; 6():25552. PubMed ID: 27174254 [TBL] [Abstract][Full Text] [Related]
9. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA. Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165 [TBL] [Abstract][Full Text] [Related]
10. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694 [TBL] [Abstract][Full Text] [Related]
11. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication. Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822 [TBL] [Abstract][Full Text] [Related]
12. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection. Kruse RL; Legras X; Barzi M Virus Res; 2021 Jan; 292():198224. PubMed ID: 33166564 [TBL] [Abstract][Full Text] [Related]
13. Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System. Ding J; Yi Z; Zai W; Wu M; Chen B; Cai Q; Zhang X; Yuan Z mBio; 2023 Apr; 14(2):e0355022. PubMed ID: 36840581 [TBL] [Abstract][Full Text] [Related]
14. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models. Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514 [TBL] [Abstract][Full Text] [Related]
15. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA]. Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223 [TBL] [Abstract][Full Text] [Related]
16. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization. Cui X; Guo JT; Hu J J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus. Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553 [TBL] [Abstract][Full Text] [Related]
19. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage. Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008 [TBL] [Abstract][Full Text] [Related]
20. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients. Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]